Venture Round - Diasome Pharmaceuticals

Venture Round - Diasome Pharmaceuticals

Investment Firm

Overview

Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

Announced Date

Jul 05, 2017

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

Participant Investors

3

Investor Name
Participant InvestorBlack Beret Life Sciences
Participant InvestorJDRF T1D Fund
Participant InvestorMedicxi

Round Details and Background

Diasome Pharmaceuticals raised $30000000 on 2017-07-05 in Venture Round

Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 08, 2022
Venture Round - Diasome Pharmaceuticals
-16.7M
Jun 30, 2023
Venture Round - Diasome Pharmaceuticals
-9.0M
Jul 05, 2017
Venture Round - Diasome Pharmaceuticals
4-30.0M
Apr 13, 2009
Debt Financing - Diasome Pharmaceuticals
-12.9M

Recent Activity

There is no recent news or activity for this profile.